Form 4: Rocket Pharmaceuticals Director David Southwell Exercises Options and Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Director David Southwell exercised stock options and sold shares of Rocket Pharmaceuticals (RCKT) to cover tax obligations.

Summary

  • On April 12, 2024, Director David Southwell exercised stock options to acquire 70,000 shares of Rocket Pharmaceuticals common stock at a price of $4.342 per share.
  • Also on April 12, 2024, Southwell sold 59,716 shares at a weighted average price of $24.224 and 10,284 shares at a weighted average price of $25.156.
  • On April 15, 2024, Southwell exercised options to acquire 29,624 shares at $4.342 per share.
  • On April 15, 2024, Southwell sold 10,000 shares at a weighted average price of $24.052.
  • The sales were made to cover certain tax obligations.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects routine transactions (option exercise and share sales for tax obligations) by a company director. It doesn't inherently indicate positive or negative prospects for the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the increased number of shares in the market.

Key Dates

DateDescription
04/12/2024Director exercised stock options for 70,000 shares and sold 59,716 and 10,284 shares.
04/15/2024Director exercised stock options for 29,624 shares and sold 10,000 shares.
04/16/2024Filing date of the Form 4.
08/28/2024Expiration date of stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.